Astex Pharmaceuticals, Inc. · Dublin, CA United States (NASDAQ: ASTX)
| 4140 Dublin Blvd., Ste. 200 | Phone: 925-560-0100 |
| Dublin, CA | Fax: 925-560-0101 |
| 94568 | |
| United States | 
Map This Company |
Astex Pharmaceuticals, Inc. Rankings
| Russell 2000 (June 2011) |
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Astex Pharmaceuticals, formerly SuperGen, fights for a better way to treat cancer. The company focuses on compounds in preclinical and early-stage clinical development. Its development pipeline includes candidates aiming to treat conditions such as lung cancer and leukemia. Astex Pharmaceuticals also has preclinical cancer research programs conducted in partnership with
Astex Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: ASTX Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 149 |
Executives
20 executives listed for Astex Pharmaceuticals, Inc.'s Dublin, CA location.
| Chairman, President, and CEO | James Manuso | |
|---|---|---|
| CFO and Secretary | Michael Molkentin | |
| VP Regulatory and Quality Affairs | David Smith |